Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
04/2006
04/25/2006US7034132 Nucleic acid sequences that encode G- coupled protein-receptor related polypeptides; diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving these human nucleic acids and proteins
04/25/2006US7034131 Antibody therapy; immobilization
04/25/2006US7034118 Isolation nucleic acids; genetic engineering
04/25/2006US7034116 Methyltransferase gene and enzyme
04/25/2006US7034115 Transposase and method of gene modification
04/25/2006US7034105 Endothelial growth factors (Flt4); glycoproteins; tyrosine kinases; immunoglobulins
04/25/2006US7034010 Gene delivery vectors, such as, for example, recombinant FIV vectors, and methods of using such vectors are provided for use in treating or preventing retinal diseases of the eye and diseases of the brain associated with lysosomal storage
04/25/2006US7034007 Low adenosine anti-sense oligonucleotide, compositions, kit & method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) & surfactant depletion
04/25/2006US7034006 Use of lipid conjugates in the treatment of disease
04/25/2006US7033981 Alkaline cellulase variants
04/25/2006US7033830 Antisense modulation of MyD88 expression
04/25/2006US7033827 Prostate-specific polynucleotide compositions
04/25/2006US7033825 Nucleotide sequences coding polypeptide for use in the treatment of nephritis, cancer and kidney disorders
04/25/2006US7033824 Plasmids for use as tools in genetic engineering
04/25/2006US7033818 Genetically engineered polyketide synthase for use in generation of polyketides
04/25/2006US7033816 Activators of cyclin-dependent kinases
04/25/2006US7033815 Biosynthesis of S-adenosylmethionine in a recombinant yeast strain
04/25/2006US7033810 Sitosterolemia susceptibility gene (SSG): compositions and methods of use
04/25/2006US7033809 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
04/25/2006US7033808 Carbonyl reductase, gene thereof and method of using the same
04/25/2006US7033806 HY2 family of bilin reductases
04/25/2006US7033805 Contains amino acid motifs of a serine proteinase, a nucleotide triphosphatase (NTPase), and an RNA helicase.
04/25/2006US7033796 cloned from cDNA library of human liver carcinoma cell line using PCR amplification; host cells
04/25/2006US7033793 Genes and proteins can be used in making transgenic animals and in assays designed to determine the likelihood of an individual developing cardiomyopathy
04/25/2006US7033790 Proteins and nucleic acids encoding same
04/25/2006US7033786 Identification and isolation of DNA and recombinant production of polypeptides
04/25/2006US7033785 Comprises nucleotide sequences coding membrane protein for diagnosing, preventing and treating cell proliferative, inflammatory or tumor disorders
04/25/2006US7033779 Method for preparing steroids modified by yeast fermentation
04/25/2006US7033764 Method for sequencing nucleic acid molecules
04/25/2006US7033762 Single nucleotide amplification and detection by polymerase
04/25/2006US7033760 Metallic solid supports modified with nucleic acids
04/25/2006US7033759 Allelic opiate membrane protein for determining susceptibility of individuals to addictive diseases; monitoring response to analgesics and learning enhancement agents
04/25/2006US7033758 Detecting preferential nucleotide sequences in samples; obtain tissue, samples, incubate with oligonucleotide probes, wash, detect signal from probes
04/25/2006US7033756 detection of gene overexpression by binding transcription factor sites
04/25/2006US7033755 Diagnostics and therapeutics for glaucoma
04/25/2006US7033754 comprises identifier binding ligands; solid phase synthesis
04/25/2006US7033753 Compositions and methods for nonenzymatic ligation of oligonucleotides and detection of genetic polymorphisms
04/25/2006US7033752 Spinal muscular atrophy diagnostic methods
04/25/2006US7033749 Detection of preferential nucleotidse sequences; obtain sample, incubate with probe, detect signal, recover nucleotide sequences
04/25/2006US7033748 Detection of prefrential microorganisms in sample, obtain cells, culture, propagate detect expression of bacterial prteins, the presence of bacterial protein indnicates infection
04/25/2006US7033592 Useful in vaccines, and monoclonal antibodies against said immunogenic surface proteins; hybridoma cell line that produes said antibodies; use in diagnostic kits for determining presence, onset, or decrease in Leptospiral infection
04/25/2006US7033589 γ-1 anti-human CD23 monoclonal antibodies and use thereof as therapeutics
04/20/2006WO2006041934A2 Methods and compositions for improving recombinant protein production
04/20/2006WO2006040448A1 Universal primers and their use for detecting and identifying plant materials in complex mixtures
04/20/2006WO2006039806A1 Depression of herg k+ channel function in mammalian cells and applications to the control of cancer cells division
04/20/2006WO2005118802A3 Targeting pseudotyped retroviral vectors
04/20/2006WO2005117859A3 Methods of diagnosing cardiovascular disease
04/20/2006WO2005089315A3 Methods and compositions related to skcg-1, a tumor suppressor gene
04/20/2006WO2005059108A3 Gene expression profiles and methods of use
04/20/2006WO2005049832A3 FcϜRIIA-SPECIFIC NUCLEIC ACID INTERFERENCE
04/20/2006WO2005047314A3 Fgf-beta binding and supported peptides
04/20/2006WO2005046606A3 Compositions and methods for diagnosing and treating chronic lymphocytic leukemia
04/20/2006WO2004065577A3 Polynucleotides and polypeptides associated with the nf-kb pathway
04/20/2006WO2004051222A3 Methods for the identification of agents for the treatment of seizures, neurological diseases, endocrinopathies and hormonal diseases
04/20/2006WO2004044164A3 Method for identifying risk of melanoma and treatments thereof
04/20/2006WO2004044011A3 Combinatorial libraries of monomer domains
04/20/2006US20060085867 genetic ablation of reproductive tissues in angiosperm and gymnosperm species; transgenic plant, H102E barnase mutant is capable of disrupting reproductive development of at least one of a male reproductive structure in a plant
04/20/2006US20060084799 Human cDNA clones comprising polynucleotides encoding polypeptides and methods of their use
04/20/2006US20060084798 Members of the basic helix-loop-helix-PAS (bHLH-PAS)superfamily of transcription regulators; alpha -class hypoxia-inducible factors; circadian rhythm disorders; binding partners for circadian responsive factors; transcription stimulation of genes having an E-box transcription control element
04/20/2006US20060084797 High affinity TGFbeta nucleic acid ligands and inhibitors
04/20/2006US20060084796 Sequence-determined DNA encoding methyltransferases
04/20/2006US20060084792 Versatile platform for nanotechnology based on circular permutations of chaperonin protein
04/20/2006US20060084791 Purified polypeptide, isolated nucleic acids encoding said polypeptide, vectors and use thereof
04/20/2006US20060084790 P-Rex1, a ptdins (3,4,5) p3-g-beta-gamma-regulated guanine-nucleotide exchange factor for rac
04/20/2006US20060084621 Compositions and methods for inhibiting expression of anti-apoptotic genes
04/20/2006US20060084620 RNA interference in respiratory epitheial cells
04/20/2006US20060084619 mesencephalic astrocyte-derived neurotrophic factor polypeptide; shown to protect the survival of embryonic mesencephalic dopaminergic neurons in culture
04/20/2006US20060084618 Adiponectin promoter and use thereof
04/20/2006US20060084600 Human homologues of fused gene
04/20/2006US20060084163 Plant-derived alkaline alpha-galactosidase
04/20/2006US20060084162 Catalytic domains of beta(1,4)-galactosyltransferase I having altered donor and acceptor specificities, domains that promote in vitro protein folding, and methods for their use
04/20/2006US20060084157 Hydrogen production
04/20/2006US20060084155 transferase for producing 4-hydroxybutyryl-Co A (4HB) containing polyhydroxyalkanoate (PHAs) from cheap carbon sources such as sugars and fatty acids
04/20/2006US20060084149 Forming complex in which single-stranded nucleic acid is bound to a double-stranded beta -1,3-glucan which as 1,6-glucopyranoside branch and is chemically modified through periodate oxidation and reductive amination so as to impart nucleic acid-binding functional groups; for use as an antisense agent
04/20/2006US20060084148 April-a novel protein with growth effects
04/20/2006US20060084147 Apo-2 receptor
04/20/2006US20060084145 sRAGE mimetibody, compositions, methods and uses
04/20/2006US20060084144 Genetic engineering; oligonucleotide detector; identification and isolation of novel DNA; transmembrane domain-deleted or transmembrane domain-inactivated protein; soluble extracellular domains; PRO polypeptide
04/20/2006US20060084143 Screen for agonists and antagonists; treat solid tumors, vascular deficiencies; polypeptide, polynucleotide, plasmid; chemotherapeutic agents, alkylating agents, antimetabolites, vinca alkaloids, plant extracts, nitrosoureas, topoisomerase inhibitors, platinum analogs, adrenocortical suppressants
04/20/2006US20060084142 tyrosine kinase; screening for inhibitors of PDGFRA; gastrointestinal stromal tumor (GIST)
04/20/2006US20060084141 Biosynthetic gene cluster for the maytansinoid antitumor agent ansamitocin
04/20/2006US20060084140 Polynucleotide encoding a novel human G-protein coupled receptor, HGPRBMY39
04/20/2006US20060084139 Genetic engineering; oligonucleotide detector; identification and isolation of novel DNA; transmembrane domain-deleted or transmembrane domain-inactivated protein; soluble extracellular domains; PRO polypeptide
04/20/2006US20060084138 Genetic engineering; oligonucleotide detector; identification and isolation of novel DNA; transmembrane domain-deleted or transmembrane domain-inactivated protein; soluble extracellular domains; PRO polypeptide
04/20/2006US20060084121 OX2 receptor homologs
04/20/2006US20060084119 Preparing budding virus expressing mammalian transporter having transporter activity by culturing host cell infected with budding virus comprising gene encoding transporter and is recombinantly expressing transporter, expressing transporter on envelope of budding virus released from host cell, harvesting
04/20/2006US20060084117 Galphaq protein variants and their use in the analysis and discovery of agonists and antagonists of chemosensory receptors
04/20/2006US20060084111 Method for gene identification signature (GIS) analysis
04/20/2006US20060084109 Regulated aptamer therapeutics
04/20/2006US20060084105 Arrays for detection of products of mRNA splicing
04/20/2006US20060084102 Methods for determining precise HERG interactions by mutagenesis
04/20/2006US20060084100 Information nucleic acid and information nucleic acid composition using the same
04/20/2006US20060084094 Conjugates for use in hepatocyte free uptake assays
04/20/2006US20060084093 Packaging cells comprising codon-optimized gagpol sequences and lacking lentiviral accessory proteins
04/20/2006US20060084087 Using presence of myofibrillogenesis regulator 1 (MR-1) gene as diagnostic tool in detection of paroxysmal dystonic choreoathetosis
04/20/2006US20060084086 Proteins, polynucleotides encoding them and methods of using the same
04/20/2006US20060084085 Methods and compositions for modulating Bax-mediated apoptosis
04/20/2006US20060084084 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/20/2006US20060084082 186 human secreted proteins
04/20/2006US20060084080 Methods and kits for the selection of animals having certain milk production capabilities, based on the analysis of a polymorphism in the somatotropin receptor gene